Tag: Fulcrum

The Force: the Cellulosic biofuels tax credit is back, but is it really needed?

The Force: the Cellulosic biofuels tax credit is back, but is it really needed?

January 3, 2013 |

Finding it hard to explain to taxpayers why the PTC is needed, for the jump to cellulosic biofuels lightspeed, or to ward off predatory fossil-fuel evildoers? Turns out, The Force may not be needed after all.  So, the fiscal cliff was averted in a last minute-deal by DC lawmakers. Sort of. For now. Or […]

Read More

What happens in Vegas…the biofuels edition

What happens in Vegas…the biofuels edition

August 5, 2012 |

Creative financing keeping numerous advanced biofuels companies on the march, despite political uncertainty. Fiberight, Zeachem in focus. Which strategics are next? What rule changes can USDA make to accelerate commercialization? Although the USDA is trying to inject some mystery into the announcement, tomorrow USDA Under Secretary for Rural Development Dallas Tonsager and Senate Majority Leader […]

Read More

The Intrepid Investor: Ceres delays IPO; others in IPO queue shift, accelerate strategies

The Intrepid Investor: Ceres delays IPO; others in IPO queue shift, accelerate strategies

February 10, 2012 |

In this two-part series, we look at the IPO market for industrial biotech stocks. Today, we look at 10 companies in the IPO queue right now. Who’s been revising their prospectus, and what does that mean? In Part II of our series, we look today at Ceres, Myriant, PetroAlgae, BioAmber, Elevance, Genomatica, Enerkem, Mascoma, and […]

Read More

Come On Seven: Investors weigh options, as 7 companies near key biofuels milestones

Come On Seven: Investors weigh options, as 7 companies near key biofuels milestones

[ 0 ] April 7, 2011 |

As seven projects aim for important milestones, investors face big decisions on whether advanced biofuels companies, even after the run-up in share prices, are still undervalued. Yesterday on the NASDAQ, Gevo hit another all-time high,  jumping 7.36 percent to an all-time high of $24.65, and the stock is now 64 percent above its $15 debut […]

Read More